These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7390860)

  • 1. Do amino acids reverse the sickling of erythrocytes containing hemoglobin S?
    Shirahama K; Kubota S; Yang JT
    Hemoglobin; 1980; 4(2):149-55. PubMed ID: 7390860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sickling in erythrocytes by amino acids.
    Rumen NM
    Blood; 1975 Jan; 45(1):45-8. PubMed ID: 803109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of in vitro sickling by liposome-mediated transport of amino acids into intact human red blood cells.
    Kumpati J
    Biochem Biophys Res Commun; 1982 Mar; 105(2):482-7. PubMed ID: 7092867
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of oxygen affinity and gelation of hemoglobin S crosslinked by reaction with methyl acetimidate.
    Chao TL; Berenfeld MR; Gelbart T; Gabuzda TG
    Hemoglobin; 1981; 5(1):47-72. PubMed ID: 7204094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisickling effect of chrysin is associated with modulation of oxygenated and deoxygenated haemoglobin via alteration of functional chemistry and metabolic pathways of human sickle erythrocytes.
    Nwankwo HC; Idowu AA; Muhammad A; Waziri AD; Abubakar YS; Bashir M; Erukainure OL
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S108-S124. PubMed ID: 34151613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of anthocyanin extracts from Justicia secunda Vahl on the solubility of haemoglobin S and membrane stability of sickle erythrocytes.
    Mpiana PT; Ngbolua KN; Bokota MT; Kasonga TK; Atibu EK; Tshibangu DS; Mudogo V
    Blood Transfus; 2010 Oct; 8(4):248-54. PubMed ID: 20967165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
    Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
    Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding antisickling agents and the sickling process.
    Godwin M; Baysinger M
    Nurs Clin North Am; 1983 Mar; 18(1):207-14. PubMed ID: 6550864
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of 2-imidazolines as anti-sickling agents.
    Chang H; Ewert SM; Nagel RL
    Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible use of non-neuroleptic isomers of anti-psychotics in anti-sickling therapy.
    Ohnishi ST; Devlin MT; Sato T; Hashimoto K; Singer M
    Eur J Pharmacol; 1981 Oct; 75(2-3):121-5. PubMed ID: 6119213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia.
    Imaga NA
    ScientificWorldJournal; 2013; 2013():269659. PubMed ID: 23476125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
    Keidan AJ; Sowter MC; Johnson CS; Marwah SS; Stuart J
    Clin Sci (Lond); 1989 Apr; 76(4):357-62. PubMed ID: 2714049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bepridil as an antisickling agent: membrane internalization and cell rigidity.
    Johnson RM; Acquaye C; Féo C; Sarnaik S
    Am J Hematol; 1994 Aug; 46(4):310-8. PubMed ID: 8037182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-deoxypyridoxal as a potential anti-sickling agent.
    Benesch R; Benesch RE; Edalji R; Suzuki T
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1721-3. PubMed ID: 266212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sickling process in relation to clinical manifestations.
    Bellingham AJ
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():23-5. PubMed ID: 4536364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted modification of furan-2-carboxaldehydes into Michael acceptor analogs yielded long-acting hemoglobin modulators with dual antisickling activities.
    Omar AM; Abdulmalik O; El-Say KM; Ghatge MS; Cyril-Olutayo M; Paredes S; Al-Awadh M; El-Araby ME; Safo MK
    Chem Biol Drug Des; 2024 Jan; 103(1):e14371. PubMed ID: 37798397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.